Gilead looks to ‘redefine’ HIV PrEP market with 2025 launch of long-acting Sunlenca zbecker Fri, 08/09/2024 – 11:06 More: Gilead looks to 'redefine' HIV PrEP market with 2025 launch of long-acting Sunlenca Source: fierce
read moreAbbVie taps Melissa Joan Hart to explain it all at annual ‘Science of Skin’ event apark Fri, 08/09/2024 – 10:39 More: AbbVie taps Melissa Joan Hart to explain it all at annual ‘Science of Skin’ event Source: fierce
read moreLegend Biotech CEO takes ‘close look at business’ amid geopolitical risk, M&A rumor aliu Fri, 08/09/2024 – 09:59 More: Legend Biotech CEO takes ‘close look at business’ amid geopolitical risk, M&A rumor Source: fierce
read morePurdue, after playing major role in US opioid epidemic, wins FDA nod for overdose-reversal injection fkansteiner Fri, 08/09/2024 – 09:14 More: Purdue, after playing major role in US opioid epidemic, wins FDA nod for overdose-reversal injection Source: fierce
read moreStartup Vivint Pharma to spend $48M to build injectables plant in India jkeenan Fri, 08/09/2024 – 07:45 More: Startup Vivint Pharma to spend M to build injectables plant in India Source: fierce
read more
The study revealed that 13% of patients have a genetic form of the neurological disease More: Study reveals genetic variants are more common in Parkinson’s disease patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals